{
    "clinical_study": {
        "@rank": "126150", 
        "acronym": "STIFFNESS", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effects of fimasartan on arterial stiffness in\n      patients with hypertension"
        }, 
        "brief_title": "Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion", 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who agree to participate in this study and give written informed consent\n\n          -  Subjects whose sitting diastolic blood pressure measured at placebo visit and\n             baseline are more than 90 mmHg and/or systolic blood pressure are more than 140 mmHg\n\n          -  Subjects who are naive to anti-hypertensive treatment\n\n          -  Subjects considered to understand the study, be cooperative, and able to be\n             followed-up until the end of the study\n\n        Exclusion Criteria:\n\n          -  Subjects who are hypersensitive to angiotensin type 1-receptor blockers\n\n          -  Subjects with secondary hypertension\n\n          -  Subjects with severe hypertension (systolic blood pressure >= 180 mmHg OR diastolic\n             blood pressure >= 110)\n\n          -  Severe cardiac disease (heart failure, ischemic heart disease, peripheral vascular\n             disease, moderate valvular disease, arrhythmia requiring treatment, cardiomyopathy,\n             etc.)\n\n          -  Subjects with chronic obstructive pulmonary disease or history\n\n          -  Clinically significant renal dysfunction (Creatinine 2.0 mg/dL) and liver dysfunction\n             (ALT, AST > 2x UNL)\n\n          -  Subjects with life expectancy of less than 2 years due to non-cardiac disease\n\n          -  Subjects with history or evidence of abuse of drugs or alcohol within 2 years\n\n          -  Severe insulin-dependent diabetes mellitus or intractable diabetic patient\n             (dose/regimen change of oral hypoglycemic agent, insulin use)\n\n          -  Severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, within 6\n             months)\n\n          -  Wasting diseases, autoimmune diseases (rheumatoid arthritis, systemic lupus\n             anticoagulants, etc.), history of connective tissue disease or ongoing disease.\n\n          -  Women with pregnancy and breast feeding\n\n          -  Women planning to be pregnant or without admitted contraception despite of\n             probability of pregnancy (Women who underwent sterilization operation are excluded.\n             Fertile women without such surgery should undergo pregnancy test and can participate\n             only with negative result. Intermittent abstinence like basic body temperature\n             method, natural period method are not considered admitted contraception and no\n             hormonal contraception is allowed.).\n\n          -  Subjects who are participating in other clinical trials for investigating agents or\n             have taken other clinical trial medication within 4 weeks before screening visit.\n\n          -  Subjects judged to be inappropriate by the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Multiple secondary and tertiary centers"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022774", 
            "org_study_id": "CN-KKH-01"
        }, 
        "intervention": {
            "description": "Fimasartan 60 ~ 120 mg/po take one tablet once a day", 
            "intervention_name": "Fimasartan", 
            "intervention_type": "Drug", 
            "other_name": "BR-A-657-K"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 22, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Suncheon", 
                        "country": "Korea, Republic of", 
                        "state": "Jeollanamdo"
                    }, 
                    "name": "St Carollo Hospital"
                }, 
                "investigator": {
                    "last_name": "Dong Han Kim, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gwangju", 
                        "country": "Korea, Republic of", 
                        "zip": "501-757"
                    }, 
                    "name": "Chonnam National University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Kye Hun Kim, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hyun Ju Yoon, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jae Yeong Cho, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gwangju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gwanju Veterans Hospital"
                }, 
                "investigator": {
                    "last_name": "Seon-Ho Hwang", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gwangju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gwagnju Christian Hospital"
                }, 
                "investigator": {
                    "last_name": "Dong Goo Kang, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iksan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Wonkwang University Hospital"
                }, 
                "investigator": {
                    "last_name": "Sang-Jae Lee, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeonju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Jeonbuk National University Hospital"
                }, 
                "investigator": {
                    "last_name": "Seon-Hwa Lee", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeonju", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Jeonju Jesus Hospital"
                }, 
                "investigator": {
                    "last_name": "Seong-Hui Jeon", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Single-arm, Open, Clinical Study to Evaluate the Effects of Fimasartan on Arterial Stiffness in Patients With Hypertension", 
        "overall_contact": {
            "email": "christiankyehun@hanmail.net", 
            "last_name": "Kye Hun Kim, MD", 
            "phone": "82-62-220-6266"
        }, 
        "overall_official": {
            "affiliation": "Chonnam National University Hospital", 
            "last_name": "Kye Hun Kim, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Improvement of carotid arterial stiffness measured by echocardiography", 
            "measure": "Improvement of carotid radial strain value", 
            "safety_issue": "No", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022774"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement in brachial-ankle pulse wave velocity (baPWV)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Improvement in augmentation index (AIx)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Improvement in carotid distensibility", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Improvement in sitting systolic blood pressure (SiSBP)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Improvement in sitting diastolic blood pressure (SiDBP)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "measure": "Improvement in central blood pressure (BP)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Boryung Pharmaceutical Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boryung Pharmaceutical Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}